The present invention is directed to 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide or a pharmaceutically acceptable salt thereof for the treatment of a disease associated with elevated blood uric acid levels, such as hyperuricemia or gout. The invention is also directed to the tosylate salt of 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide.
申请公布号
HK1196535(A1)
申请公布日期
2016.10.28
申请号
HK20140109958
申请日期
2014.10.07
申请人
PFIZER LIMITED
发明人
ALI,ZAHID Z;BUTCHER,KENNETH JOHN KJ;BUTT,RICHARD PHILIP RP;FELSTEAD,STEPHER JOHN SJ;GLATT,SOPHIE S;MCKERNAN,RUTH MITCHELL RM;PANESAR,MANINDER M